MRE-269 (ACT-333679)
Important Notice: For research use only. We do not sell to patients.
Loading distributor info...
Important Notice: For research use only. We do not sell to patients.
Loading distributor info...
Discription | MRE-269 is an active metabolite of selexipag, and acts as a selective IP receptor agonist. | ||
---|---|---|---|
Targets |
|
Catalog Num | A18322 |
---|---|
Formula | C25H29N3O3 |
Molecular Weight | 419.52 |
CAS Number | 475085-57-5 |
SMILES | OC(COCCCCN(C(C)C)C1=NC(C2=CC=CC=C2)=C(C3=CC=CC=C3)N=C1)=O |
Synonyms | MRE269, MRE 269, ACT333679, ACT 333679 |
Storage | Store lyophilized at -20ºC, keep desiccated. |
In vitro | DMSO | 83 mg/mL (197.84 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 23.84 mL | 119.18 mL | 238.37 mL |
0.5 mM | 4.77 mL | 23.84 mL | 47.67 mL |
1 mM | 2.38 mL | 11.92 mL | 23.84 mL |
5 mM | 0.48 mL | 2.38 mL | 4.77 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2